double blinded studies, page-8

Thanks for the post Kosenar, it's very interesting to see Steven Mercer directly address questions regarding the level of scientific rigour in Vitrogro's clinical studies to date.

Also thank you to Unlce Panda for the links, I'm now much more sceptical of poorly designed studies (or the lack of study) than I was half an hour a go! ;-)

I'm of the opinion that a randomised, double-blind study would be good for Vitrogro and for shareholder's long term interests even if it's not the norm in the wound care industry, although I do think that the company really ought to focus on commercialisation in Europe for the immediate future.

mattkid76, I'm not sure I share your enthusiasm regarding the reduction or eradication of pain in previous studies after reading Uncle Panda's links.

There would appear to be clear issues concerning the placebo effect, observer bias, selection bias, the study effect and regression to the mean that the clinical studies to date don't appear designed to address, particularly in the area of pain management.